Back to search
Scientific Name: Belinostat
Brand Name: Beleodaq
Company Owner: Not Available
Mechanism Of Action Belinostat inhibits the activity of histone deacetylase (HDAC) thus prevents the removal of acetyl groups from the lysine residues of histones and some non-histone proteins. In vitro, belinostat caused the accumulation of acetylated histones and other proteins, increased the expression of tumor-suppressor genes. It ultimately induces cell cycle arrest, inhibition of angiogenesis and/or apoptosis of some transformed cells.
Description of the Drug: Belinostat is a histone deacetylase (HDAC) inhibitor used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) .
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from